(S)-nicotine increases expression ISO RGD:1348038 6480464 Nicotine results in increased expression of BMI1 mRNA, Nicotine results in increased expression of BMI1 protein CTD PMID:23219715 (S)-nicotine multiple interactions ISO RGD:1348038 6480464 SNAI1 mutant form inhibits the reaction [Nicotine results in increased expression of BMI1 mRNA] CTD PMID:23219715 1,2-dimethylhydrazine affects expression ISO RGD:1316582 6480464 1, 2-Dimethylhydrazine affects the expression of BMI1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1316582 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of BMI1 mRNA CTD PMID:22206623 1,4-benzoquinone increases expression ISO RGD:1316582 6480464 quinone results in increased expression of BMI1 mRNA CTD PMID:28986286 17beta-estradiol increases expression ISO RGD:1348038 6480464 Estradiol results in increased expression of BMI1 mRNA CTD PMID:24424067 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316582 6480464 Tetrachlorodibenzodioxin affects the expression of BMI1 mRNA CTD PMID:21570461 , PMID:24680724 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1316582 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BMI1 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1348038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BMI1 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1348038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BMI1 mRNA CTD PMID:28628672 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1348038 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of BMI1 mRNA, [Decitabine co-treated with trichostatin A] results in increased expression of BMI1 protein CTD PMID:17185465 7,12-dimethyltetraphene increases expression ISO RGD:1316582 6480464 9 more ... CTD PMID:24792773 7,12-dimethyltetraphene multiple interactions ISO RGD:1316582 6480464 Butyric Acid inhibits the reaction [9 more ... CTD PMID:24792773 all-trans-retinoic acid increases expression ISO RGD:1348038 6480464 Tretinoin results in increased expression of BMI1 mRNA CTD PMID:21934132 , PMID:23724009 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of BMI1 mRNA CTD PMID:30779732 Aroclor 1254 decreases expression ISO RGD:1316582 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BMI1 mRNA CTD PMID:23650126 arsane increases expression ISO RGD:1316582 6480464 Arsenic results in increased expression of BMI1 protein CTD PMID:22843710 arsane affects methylation ISO RGD:1348038 6480464 Arsenic affects the methylation of BMI1 gene CTD PMID:25304211 arsane increases response to substance ISO RGD:1316582 6480464 BMI1 protein results in increased susceptibility to Arsenic CTD PMID:22843710 arsane multiple interactions ISO RGD:1316582 6480464 BMI1 protein promotes the reaction [Arsenic results in decreased expression of CDKN2A mRNA], BMI1 protein promotes the reaction [Arsenic results in decreased expression of CDKN2A protein] CTD PMID:22843710 arsenic atom increases expression ISO RGD:1316582 6480464 Arsenic results in increased expression of BMI1 protein CTD PMID:22843710 arsenic atom affects methylation ISO RGD:1348038 6480464 Arsenic affects the methylation of BMI1 gene CTD PMID:25304211 arsenic atom increases response to substance ISO RGD:1316582 6480464 BMI1 protein results in increased susceptibility to Arsenic CTD PMID:22843710 arsenic atom multiple interactions ISO RGD:1316582 6480464 BMI1 protein promotes the reaction [Arsenic results in decreased expression of CDKN2A mRNA], BMI1 protein promotes the reaction [Arsenic results in decreased expression of CDKN2A protein] CTD PMID:22843710 arsenous acid decreases response to substance ISO RGD:1348038 6480464 BMI1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:24571310 benzo[a]pyrene increases expression ISO RGD:1316582 6480464 Benzo(a)pyrene results in increased expression of BMI1 mRNA CTD PMID:19770486 bisphenol A multiple interactions ISO RGD:1348038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BMI1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMI1 mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:1316582 6480464 bisphenol A results in decreased expression of BMI1 mRNA CTD PMID:33221593 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of BMI1 gene CTD PMID:28505145 butan-1-ol multiple interactions ISO RGD:1348038 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BMI1 mRNA CTD PMID:29432896 butyric acid decreases response to substance ISO RGD:1348038 6480464 BMI1 protein results in decreased susceptibility to Butyric Acid CTD PMID:24571310 butyric acid multiple interactions ISO RGD:1316582 6480464 Butyric Acid inhibits the reaction [9 more ... CTD PMID:24792773 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of BMI1 promoter CTD PMID:22457795 carbon nanotube increases expression ISO RGD:1316582 6480464 Nanotubes more ... CTD PMID:25620056 casticin multiple interactions ISO RGD:1348038 6480464 casticin promotes the reaction [MIR148A mRNA results in decreased expression of BMI1 mRNA] more ... CTD PMID:32268151 casticin decreases expression ISO RGD:1348038 6480464 casticin results in decreased expression of BMI1 mRNA CTD PMID:32268151 cisplatin decreases response to substance ISO RGD:1348038 6480464 BMI1 protein results in decreased susceptibility to Cisplatin CTD PMID:21311599 , PMID:21445297 cisplatin decreases expression ISO RGD:1348038 6480464 Cisplatin results in decreased expression of BMI1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1348038 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of BMI1 mRNA more ... CTD PMID:21311599 more ... cobalt dichloride decreases expression ISO RGD:1348038 6480464 cobaltous chloride results in decreased expression of BMI1 mRNA CTD PMID:19320972 copper atom increases expression EXP 6480464 Copper results in increased expression of BMI1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of BMI1 mRNA CTD PMID:30556269 crocidolite asbestos decreases expression ISO RGD:1316582 6480464 Asbestos, Crocidolite results in decreased expression of BMI1 mRNA CTD PMID:29279043 dexamethasone multiple interactions ISO RGD:1348038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BMI1 mRNA more ... CTD PMID:28628672 diallyl trisulfide affects expression ISO RGD:1348038 6480464 diallyl trisulfide affects the expression of BMI1 protein CTD PMID:27129776 diarsenic trioxide decreases response to substance ISO RGD:1348038 6480464 BMI1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:24571310 doxorubicin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of BMI1 protein] CTD PMID:24902966 doxorubicin multiple interactions ISO RGD:1316582 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of BMI1 protein] CTD PMID:24902966 doxorubicin decreases expression ISO RGD:1316582 6480464 Doxorubicin results in decreased expression of BMI1 protein CTD PMID:24902966 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BMI1 protein CTD PMID:24902966 doxorubicin decreases response to substance EXP 6480464 BMI1 protein results in decreased susceptibility to Doxorubicin CTD PMID:24902966 epoxiconazole increases expression ISO RGD:1316582 6480464 epoxiconazole results in increased expression of BMI1 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1348038 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BMI1 mRNA CTD PMID:29432896 ethanol affects splicing ISO RGD:1316582 6480464 Ethanol affects the splicing of BMI1 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1316582 6480464 Ethanol affects the expression of BMI1 mRNA CTD PMID:30319688 folic acid decreases expression ISO RGD:1316582 6480464 Folic Acid results in decreased expression of BMI1 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1316582 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of BMI1 mRNA CTD PMID:22206623 genistein increases expression ISO RGD:1316582 6480464 Genistein results in increased expression of BMI1 mRNA CTD PMID:21048042 glucaric acid multiple interactions ISO RGD:1316582 6480464 Glucaric Acid inhibits the reaction [9 more ... CTD PMID:24792773 glutathione increases abundance ISO RGD:1348038 6480464 BMI1 protein results in increased abundance of Glutathione CTD PMID:21445297 gold atom decreases expression ISO RGD:1348038 6480464 Gold results in decreased expression of BMI1 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:1348038 6480464 Gold results in decreased expression of BMI1 mRNA CTD PMID:25523186 hydroxyurea decreases expression ISO RGD:1316582 6480464 Hydroxyurea results in decreased expression of BMI1 mRNA CTD PMID:12929121 ibrutinib decreases expression ISO RGD:1348038 6480464 ibrutinib results in decreased expression of BMI1 mRNA CTD PMID:26254443 indometacin multiple interactions ISO RGD:1348038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BMI1 mRNA more ... CTD PMID:28628672 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of BMI1 mRNA CTD PMID:20080153 lipopolysaccharide multiple interactions ISO RGD:1348038 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BMI1 mRNA CTD PMID:35811015 malathion increases expression ISO RGD:1348038 6480464 Malathion results in increased expression of BMI1 mRNA CTD PMID:32069766 monosodium L-glutamate increases expression ISO RGD:1316582 6480464 Sodium Glutamate results in increased expression of BMI1 mRNA CTD PMID:22078008 monosodium L-glutamate multiple interactions ISO RGD:1316582 6480464 [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of BMI1 mRNA CTD PMID:22078008 nickel sulfate decreases expression ISO RGD:1348038 6480464 nickel sulfate results in decreased expression of BMI1 mRNA CTD PMID:22714537 nicotinamide multiple interactions ISO RGD:1316582 6480464 Niacinamide inhibits the reaction [9 more ... CTD PMID:24792773 nicotine multiple interactions ISO RGD:1348038 6480464 SNAI1 mutant form inhibits the reaction [Nicotine results in increased expression of BMI1 mRNA] CTD PMID:23219715 nicotine increases expression ISO RGD:1348038 6480464 Nicotine results in increased expression of BMI1 mRNA, Nicotine results in increased expression of BMI1 protein CTD PMID:23219715 ozone decreases expression EXP 6480464 Ozone results in decreased expression of BMI1 mRNA CTD PMID:26667334 p-anisidine decreases expression ISO RGD:1316582 6480464 4-anisidine results in decreased expression of BMI1 mRNA CTD PMID:12929121 paclitaxel decreases expression ISO RGD:1316582 6480464 Paclitaxel results in decreased expression of BMI1 mRNA CTD PMID:12929121 paracetamol decreases expression ISO RGD:1348038 6480464 Acetaminophen results in decreased expression of BMI1 mRNA CTD PMID:21420995 , PMID:22230336 phenobarbital affects expression ISO RGD:1348038 6480464 Phenobarbital affects the expression of BMI1 mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:1316582 6480464 Phenobarbital affects the expression of BMI1 mRNA CTD PMID:23091169 phorbol 13-acetate 12-myristate decreases response to substance ISO RGD:1348038 6480464 BMI1 protein results in decreased susceptibility to Tetradecanoylphorbol Acetate CTD PMID:24571310 pyrogallol increases expression ISO RGD:1316582 6480464 Pyrogallol results in increased expression of BMI1 mRNA CTD PMID:20362636 quercetin multiple interactions ISO RGD:1316582 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of BMI1 protein] CTD PMID:24902966 quercetin increases expression ISO RGD:1316582 6480464 Quercetin results in increased expression of BMI1 protein CTD PMID:24902966 quercetin increases expression EXP 6480464 Quercetin results in increased expression of BMI1 mRNA, Quercetin results in increased expression of BMI1 protein CTD PMID:24902966 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of BMI1 protein] CTD PMID:24902966 quercetin increases response to substance EXP 6480464 BMI1 protein results in increased susceptibility to Quercetin CTD PMID:24902966 reactive oxygen species multiple interactions ISO RGD:1348038 6480464 BMI1 protein inhibits the reaction [Cisplatin results in increased abundance of Reactive Oxygen Species] CTD PMID:21445297 reactive oxygen species decreases abundance EXP 6480464 BMI1 protein results in decreased abundance of Reactive Oxygen Species CTD PMID:24902966 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1348038 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BMI1 mRNA CTD PMID:35811015 silicon atom decreases response to substance ISO RGD:1348038 6480464 BMI1 protein results in decreased susceptibility to Silicon CTD PMID:35288261 silicon dioxide increases expression ISO RGD:1348038 6480464 Silicon Dioxide analog results in increased expression of BMI1 mRNA CTD PMID:23806026 silicon dioxide decreases expression ISO RGD:1316582 6480464 Silicon Dioxide results in decreased expression of BMI1 protein CTD PMID:35288261 silicon dioxide multiple interactions ISO RGD:1348038 6480464 [BMI1 protein co-treated with Silicon Dioxide] results in decreased expression of CCND1 protein more ... CTD PMID:35288261 silicon dioxide affects expression ISO RGD:1348038 6480464 Silicon Dioxide affects the expression of BMI1 protein CTD PMID:35288261 sodium arsenite multiple interactions ISO RGD:1348038 6480464 EPAS1 mutant form inhibits the reaction [sodium arsenite results in increased expression of BMI1 protein] more ... CTD PMID:22662215 , PMID:29240254 sodium arsenite increases expression ISO RGD:1316582 6480464 sodium arsenite results in increased expression of BMI1 mRNA CTD PMID:35364107 sodium arsenite multiple interactions ISO RGD:1316582 6480464 GSK-2816126 promotes the reaction [sodium arsenite results in increased expression of BMI1 mRNA] CTD PMID:35364107 sodium arsenite affects methylation ISO RGD:1348038 6480464 sodium arsenite affects the methylation of BMI1 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:1348038 6480464 sodium arsenite results in increased expression of BMI1 mRNA, sodium arsenite results in increased expression of BMI1 protein CTD PMID:22662215 , PMID:29240254 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BMI1 mRNA CTD PMID:19072884 sodium arsenite affects expression ISO RGD:1348038 6480464 sodium arsenite affects the expression of BMI1 mRNA CTD PMID:20056578 sunitinib increases expression ISO RGD:1348038 6480464 Sunitinib results in increased expression of BMI1 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1348038 6480464 Temozolomide results in decreased expression of BMI1 mRNA CTD PMID:31758290 tetrachloromethane affects expression ISO RGD:1316582 6480464 Carbon Tetrachloride affects the expression of BMI1 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BMI1 mRNA CTD PMID:34492290 trichostatin A multiple interactions ISO RGD:1348038 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of BMI1 mRNA, [Decitabine co-treated with trichostatin A] results in increased expression of BMI1 protein CTD PMID:17185465 trichostatin A affects expression ISO RGD:1348038 6480464 trichostatin A affects the expression of BMI1 mRNA CTD PMID:28542535 triptonide affects expression ISO RGD:1316582 6480464 triptonide affects the expression of BMI1 mRNA CTD PMID:33045310 valproic acid increases expression ISO RGD:1348038 6480464 Valproic Acid results in increased expression of BMI1 mRNA CTD PMID:23179753 valproic acid decreases methylation ISO RGD:1348038 6480464 Valproic Acid results in decreased methylation of BMI1 gene CTD PMID:29154799 zinc atom decreases expression ISO RGD:1348038 6480464 Zinc deficiency results in decreased expression of BMI1 mRNA CTD PMID:22171008 zinc(0) decreases expression ISO RGD:1348038 6480464 Zinc deficiency results in decreased expression of BMI1 mRNA CTD PMID:22171008
